Nurtec ODT 75 MG tablet 8S
Ended Awarded
- Contract number
- SPE2DR26F0K10
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,457
Award facts
- Contract value 100% obligated
- $17,456.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,456.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count packages) on November 4, 2025. The contract is non-set-aside and competitively awarded, with ultimate completion scheduled for November 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support vehicle valued through December 2026.
NURTEC ODT is a migraine treatment medication, consistent with AmerisourceBergen Drug Corp's extensive portfolio of pharmaceutical products supplied to federal medical procurement needs, particularly for military and veteran healthcare systems. The Defense Logistics Agency utilizes its Medical Supply Chain to procure a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, and other critical medical commodities. AmerisourceBergen Drug Corp's demonstrated capability to meet federal procurement requirements through open competition, combined with its established role as a primary vendor for DLA's pharmaceutical supply chain, makes it well-positioned to fulfill medical supply needs across multiple therapeutic domains for the Department of Defense and affiliated healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F0K10?
SPE2DR26F0K10 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DR26F0K10 worth?
The government has obligated $17,457 on SPE2DR26F0K10.
Is contract SPE2DR26F0K10 an order under another contract?
Yes. SPE2DR26F0K10 is a delivery order under SPE2DR25D2207, an indefinite delivery contract.
Was contract SPE2DR26F0K10 competed?
The extent of competition for SPE2DR26F0K10 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award